C3d ELISA Kit

$1,380.00

The C3d ELISA Kit is intended for the quantitative determination of C3d in human serum and plasma samples. The C3d ELISA Kit is for research use only and not to be used for diagnostic procedures.

C3d ELISA Kit

C3d is a degradation fragment of complement component C3 and plays an important role in linking innate and adaptive immune responses. The complement system consists of a network of proteins and receptors that function in the circulation, tissues, and other body fluids to support immune defense and regulate inflammation. It can be activated through three pathways: the classical pathway, typically triggered by antigen-antibody complexes; the lectin pathway, initiated by the recognition of microbial carbohydrate structures; and the alternative pathway, activated through spontaneous C3 hydrolysis and amplified on surfaces that lack adequate complement regulation. All three pathways converge on the formation of C3 convertases, which cleave C3 into C3a and C3b. C3b promotes opsonization and contributes to the formation of C5 convertases, ultimately leading to activation of the terminal complement pathway and formation of the membrane attack complex (MAC).

C3d is generated through the progressive degradation of C3b, which produces intermediate fragments including iC3b and C3dg. C3dg can be further processed into C3d, a relatively stable, non-glycosylated, single-chain protein with a molecular mass of approximately 38.9 kDa. C3dg may remain the predominant circulating form, depending on the biological context and sample type. Distinguishing between native C3 and its activation products, as well as differentiating individual C3 fragments, remains challenging for many immunoassays because of shared structural regions and overlapping antibody recognition. Surface-bound C3d and related fragments also interact with complement receptor 2 (CR2/CD21) on B cells and follicular dendritic cells, helping enhance B-cell activation and regulate adaptive immune responses. C3 activation products have been investigated in association with several conditions, including transplant rejection, kidney diseases, age-related macular degeneration (AMD), and other inflammatory disorders.

In clinical research, C3d is investigated as a potential biomarker of complement activation because its presence reflects the processing of C3 and may provide information beyond measurements of total C3 or C4 concentrations. However, its interpretation requires consideration of assay specificity, as antibodies targeting epitopes within the C3d region may also recognize native C3 or other C3-derived fragments. Assays designed to measure C3d must therefore distinguish activated C3 products from intact C3 to support reliable interpretation. The conversion of C3dg to C3d and the release of C3d from cell surfaces may also influence the distribution of these fragments in biological samples. Measurement of C3d and related activation products may help researchers investigate complement activity and its contribution to inflammatory, autoimmune, renal, and transplant-related conditions.

This C3d ELISA Kit is manufactured in Netherlands by Hycult Biotech.

Size
Sensitivity 0.2 ng/mL
Dynamic Range 0.2 – 15 ng/mL
Incubation Time 1 hours 15 minutes
Sample Type Serum, Plasma
Storage 2-8°C
Alternative Names Complement Component C3d, Complement C3d

 

Product Citations